SCH 24937
Latest Information Update: 06 Dec 1994
At a glance
- Originator Schering-Plough
- Class
- Mechanism of Action Immunosuppressants
-
Orphan Drug Status
Orphan designation is assigned by a regulatory body to encourage companies to develop drugs for rare diseases.
Highest Development Phases
- Discontinued Rheumatic disorders